John Dobak
CO-Founder & Chief Executive Officer Clic Bio
John Dobak, M.D. is a physician-entrepreneur who has founded and led multiple life sciences companies across drug therapeutics medical devices. He is Chief Executive Officer of ClicBio, Inc., a venture-backed biotechnology company pursuing a novel target in obesity and metabolic disease, and Executive Chairman of Leios Therapeutics, Inc., a late-stage private company he founded to develop a next-generation body contouring therapy. He previously served as CEO of DermTech, Inc., a global leader in precision dermatology, building the company from the ground up and taking it public in 2019. He previously founded one of the first obesity medical device companies developing a novel neurostimulation approach to the disease.
Seminars
- Uncovering the role of CLIC1 in the hypothalamus as a key regulator of appetite and energy balance
- Demonstrating preclinical weight loss efficacy comparable to, or exceeding, GLP-1 therapies through selective suppression of hunger signaling
- Advancing an oral small molecule approach that avoids the gastrointestinal side effects associated with current incretin therapies
